Article
CD109 and squamous cell carcinoma
6 Apr 2018
Abstract excerpt
Squamous cell carcinoma (SCC) is well-known for its high rate of metastasis with poor prognosis. CD109 is a glycosylphosphatidylinositol-anchored cell-surface glycoprotein. Recently, CD109 emerges as a potential biomarker and a therapeutic target for SCCs. Accumulating studies have reported that CD109 is highly expressed in human SCCs of multiple organs, and may contribute to the progression of SCCs. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
